Literature DB >> 10815020

Protection by garlic against adriamycin induced alterations in the oxido-reductive status of mouse red blood cells.

M I Thabrew1, N A Samarawickrema, L G Chandrasena, S Jayasekera.   

Abstract

The effects of oral garlic supplementation on the activities of (a) the antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPX) and (b) lipid peroxidation, as assessed by malondialdehyde (MDA) production in red blood cells of normal mice and those subject to oxidative stress by chronic administration of the anti-tumour drug adriamycin has been investigated. As expected, adria-mycin administration resulted in a significant increase in MDA generation (by 105.4%) and a decrease in GPX activity (by 23.8%) in the red blood cells. Although garlic had no significant effects on the basal levels of the antioxidant enzymes or MDA generation in red blood cells of normal mice (untreated with adriamycin), at doses of 20 mg/kg or 100 mg/kg, garlic was able to decrease significantly the adriamycin induced changes in the oxido-reductive status of the red blood cells. Thus, on administration of adriamycin to mice fed diets containing 20 mg/kg or 100 mg/kg garlic, the drug-induced increase in MDA generation was 38.2% and 22.5% respectively, less than that produced by adriamycin in mice fed normal diets, containing no garlic (105.4%). Similarly, in mice fed diets providing 20 mg/kg and 100 mg/kg garlic, adriamycin was able to decrease GPX activity by only 15.1% and 7.6% respectively, less than that produced by adriamycin in rats fed normal diets, containing no garlic (23.9%). Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815020     DOI: 10.1002/(sici)1099-1573(200005)14:3<215::aid-ptr626>3.0.co;2-i

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  1 in total

1.  Hepatoprotective and antioxidant effects of single clove garlic against CCl4-induced hepatic damage in rabbits.

Authors:  Khalid Mohammed Naji; Elham Shukri Al-Shaibani; Fatima A Alhadi; Safa'a Abdulrzaq Al-Soudi; Myrene R D'souza
Journal:  BMC Complement Altern Med       Date:  2017-08-17       Impact factor: 3.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.